UK and EU regulators are raising the bar for alternative investment firms. This article explains what that means in practice for hedge funds private equity private credit and family offices.
It focuses on the shift from compliance as documentation to credibility as evidence. Where firms really get delayed or challenged is not forms. It is coherence. Governance that matches the strategy. Oversight of delegates. Valuation discipline. Distribution controls. Prudential resilience and wind down readiness.
The core message is simple. The market now prices regulatory readiness as execution quality. The firms that scale fastest will be the ones that can evidence institutional readiness early and convincingly.

When preparing for authorisation, many founders say the same thing:
“We already have a business plan. Can we submit that?”
Commercially, it sounds reasonable. Regulatorily, it rarely works.
A traditional business plan is written to attract capital. A regulatory business plan is written to earn permission. This article explains why and breaks down the differences.

Choosing between UK and EU authorisation is not just a compliance step. It is a strategic decision that shapes cost, speed to market and access to capital.
In this piece, we share how investment managers can think practically about the advantages of a UK base versus an EU platform and when a dual structure makes the most sense.